Cargando…

The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system

OBJECTIVE(S): The present study aimed to determine the immunoadjuvant efficacy of mixed cross-linked dextran microspheres (CDM) and tetanus toxoid (TT)-loaded trimethyl chitosan (TMC) nanospheres in dry powder form. MATERIALS AND METHODS: The TMC nanoparticles (NPs) containing TT were produced using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabiri, Mona, Bolourian, Haleh, Dehghan, Solmaz, Tafaghodi, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894627/ https://www.ncbi.nlm.nih.gov/pubmed/33643579 http://dx.doi.org/10.22038/ijbms.2020.49486.11313

Ejemplares similares

Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid
por: Pirouzmand, Haniyeh, et al.
Publicado: (2016)

Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid
por: Moghadam Ariaee, Faezeh, et al.
Publicado: (2012)

In vivo Evaluation of Single Dose Tetanus Toxoid Vaccine Formulation with Chitosan Microspheres
por: Manivannan, R., et al.
Publicado: (2008)

The Mucosal Adjuvant Potential of Cross-Linked Dextran Microspheres as Dry Powder
por: Tafaghodi, Mohsen, et al.
Publicado: (2012)

Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine
por: Ghalavand, Majdedin, et al.
Publicado: (2021)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations
por: Bal, Suzanne M., et al.
Publicado: (2010)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization
por: Mosafer, Jafar, et al.
Publicado: (2019)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
por: Yu, Rui, et al.
Publicado: (2016)

Preparation and Characterization of Quaternized Chitosan Coated Alginate Microspheres for Blue Dextran Delivery
por: Chen, Kuo-Yu, et al.
Publicado: (2017)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Tetanus Toxoid‐Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth
por: Herold, Joerg, et al.
Publicado: (2014)

Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India
por: Singh, Abhishek, et al.
Publicado: (2012)

A rare case of cellulitis after tetanus toxoid (TT) vaccination
por: AlBassri, Tala K., et al.
Publicado: (2020)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

Living standard and access to tetanus toxoid immunization among women in Bangladesh
por: Islam, Ummay Nayeema, et al.
Publicado: (2022)

Transcriptomic Response of Porcine PBMCs to Vaccination with Tetanus Toxoid as a Model Antigen
por: Adler, Marcel, et al.
Publicado: (2013)

Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients
por: Mitchell, Duane A., et al.
Publicado: (2015)

Maternal Tetanus Toxoid Vaccination in Benin: Evidence from the Demographic and Health Survey
por: Amoak, Daniel, et al.
Publicado: (2022)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Impairment of humoral and cellular immune response to tetanus toxoid in HTLV-1 infected individuals
por: Souza, Anselmo S, et al.
Publicado: (2014)

Diversity of the Antibody Response to Tetanus Toxoid: Comparison of Hybridoma Library to Phage Display Library
por: Sorouri, Mahsa, et al.
Publicado: (2014)

Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines
por: Lockyer, Kay, et al.
Publicado: (2015)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization
por: Mehanna, Azza, et al.
Publicado: (2020)

CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses
por: Schnabel, Christiane L., et al.
Publicado: (2022)

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
por: Kensinger, Richard, et al.
Publicado: (2022)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
por: Prygiel, Marta, et al.
Publicado: (2023)

Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4(+) T Cell Responses
por: da Silva Antunes, Ricardo, et al.
Publicado: (2017)

Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda
por: Makumbi, Fredrick, et al.
Publicado: (2018)

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization
Publicado: (1993)

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
por: Buffa, Viviana, et al.
Publicado: (2012)

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali
por: Basta, Nicole E., et al.
Publicado: (2015)

Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein
por: Abdelhameed, Ali Saber, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0lbrofi7v4orogtmk9h29j7ord